{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:25Z","timestamp":1786119505457,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/pai.0b013e3181c925aa","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T04:04:48Z","timestamp":1271477088000},"page":"250-253","source":"Crossref","is-referenced-by-count":7,"title":["MUC16 Expression and Risk of Adenocarcinoma Metastases to Peritoneum, Pleura, Leptomeninges, and Brain"],"prefix":"10.1097","volume":"18","author":[{"given":"Mahlon D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoadong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210126","first-page":"164","article-title":"Tumours of the Nervous System.","author":"Perry","year":"2007"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000163397","article-title":"Metastatic brain tumors: lung cancer","volume":"22","author":"Serizawa","year":"2009","journal-title":"Prog Neurol Surg"},{"key":"R3-9-20210126","first-page":"358","article-title":"Preoperative scanning: evaluation for metastatic disease in carcinoma of the breast, lung, colon and prostate","volume":"7","author":"Smalley","year":"1980","journal-title":"Semin Oncol"},{"key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"A Binding of ovarian cancer cell antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"R7-9-20210126","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1369\/jhc.2008.950477","article-title":"Mesothelin in leptomeninges and meningiomas","volume":"56","author":"Johnson","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0021-9258(17)42180-6","article-title":"A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5","volume":"269","author":"Yamaguchi","year":"1994","journal-title":"J Biol Chem"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1074\/jbc.270.37.21984","article-title":"Molecular cloning and expression of megakaryocyte potentiating factor cDNA","volume":"270","author":"Kojima","year":"1995","journal-title":"J Biol Chem"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-9-20210126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000478-200302000-00002","article-title":"Expression of calretin, thrombomodulin, keratin5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura","volume":"27","author":"Miettinen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R14-9-20210126","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1525-1438.1995.05030170.x","article-title":"Predictive value of the combination of serum markers, CA125, CASA and TPS in ovarian cancer","volume":"5","author":"Devine","year":"1995","journal-title":"Int J Gynecol"},{"key":"R15-9-20210126","first-page":"2141","article-title":"Role of serum tumor markers CA125 and CEA in non-small cell lung cancer","volume":"21","author":"Salgia","year":"2001","journal-title":"Anticancer Res"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000049366","article-title":"Prognostic value of serum tumor markers in patients with lung cancer","volume":"69","author":"Hatzakis","year":"2002","journal-title":"Respiration"},{"key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response to ovarian carcinoma to initial chemotherapy according to serum CA125","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0002-9378(94)90129-5","article-title":"Evaluation of tumor-associated glycoprotein-72 and CA125 serum markers in patients with gynecologic diseases","volume":"171","author":"Guadagni","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/1078-0432.CCR-05-0578","article-title":"New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, western blotting and ELISA","volume":"11","author":"Onda","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["Applied Immunohistochemistry & Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00129039-201005000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:06Z","timestamp":1786040346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129039-201005000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0b013e3181c925aa","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}